Archived Medical News Stories

<< Back to Main Archives Index

RSSArchived Drug Trial News Stories - May 2011

Date Title Comments Rating
2011-05-31 Enrollment complete in BioSante's LibiGel Phase III cardiovascular and breast cancer safety study 0 None
2011-05-31 YM announces updates on nimotuzumab clinical development program 0 None
2011-05-30 Positive results from DavosLife Natural e3 phase I clinical trial in resectable pancreatic cancer 0 None
2011-05-30 New positive Cimzia phase IIIb study data on rheumatoid arthritis presented at EULAR meeting 0 None
2011-05-27 Interim analysis of AIM-HIGH study affirms positive impact of Niaspan on HDL and triglyceride lipid values 0 None
2011-05-27 Adalimumab plus methotrexate helps achieve higher levels of disease control in early RA 0 None
2011-05-27 NHLBI stops AIM-HIGH combination clinical trial in high blood cholesterol 1 4
2011-05-27 4SC to present pre-clinical data on vidofludimus in systemic lupus erythematosus at EULAR 2011 0 None
2011-05-27 ARCA plans to expand development program for Gencaro in atrial fibrillation 0 None
2011-05-27 Nuron secures option, license deal to develop NU400 for Relapse Remitting Multiple Sclerosis 0 None
2011-05-27 Positive results from CEL-SCI's LEAPS H1N1-activated dendritic cells trial in mice 0 5
2011-05-27 Tacrolimus prevents breast cancer growth in pre-clinical studies 0 None
2011-05-27 Neurologix presents NLX-P101 Phase 2 trial in Parkinson's disease at 10th INS World Congress 0 None
2011-05-27 Tigris Pharmaceuticals begins enrollment in AFP-464 Phase 2 trial in ER-positive breast cancer 0 None
2011-05-26 Gout drug success for Novartis 0 None
2011-05-26 Specific influenza immunization strategies for RA patients may be required for future flu pandemics 0 None
2011-05-26 iBioLaunch Platform successfully expresses hookworm-derived molecule for potential vaccine 0 None
2011-05-26 Pharmasset, Bristol-Myers Squibb initiate PSI-7977 plus BMS-790052 combination Phase 2a trial in HCV 0 None
2011-05-26 BioCryst presents positive data from two BCX4208 Phase 2 studies in gout at EULAR 2011 0 None
2011-05-26 ImmunoGen's clinical data on IMGN901 and SAR3419 to be presented at ASCO 2011 0 None
2011-05-26 Mayoly-Spindler, ProteaBio complete MS1819 Phase I/IIA trial in malabsorption syndrome 0 None
2011-05-26 Boehringer Ingelheim's new afatinib-cetuximab phase Ib data in NSCLC presented at ASCO 2011 0 None
2011-05-26 NWBT accelerates addition of clinical sites for new enrollment into ongoing GBM brain cancer trial 0 None
2011-05-26 Lytix Biopharma completes two LTX-109 Phase I/IIa studies in MRSA, Gram+ skin infections 0 None
2011-05-26 Tofacitinib safe and effective for patients with rheumatoid arthritis 0 None
2011-05-26 Ardea reports additional results from lesinurad-allopurinol Phase 2b study in hyperuricemia, gout 0 None
2011-05-26 NEJM publishes ZYTIGA plus prednisone Phase 3 trial data in metastatic castration-resistant prostate cancer 0 None
2011-05-25 PolyMedix presents new pre-clinical data on antimicrobial compounds at two scientific meetings 0 None
2011-05-25 Derma Sciences announces results of DSC127 Phase 2 trial in diabetic foot ulcers at 24-weeks 0 None
2011-05-25 Pathway receives FDA approval to commence PWT33597 Phase 1 study in advanced solid tumors 0 None
2011-05-25 Avanafil phase 3 trial in ED following radical prostatectomy meets primary endpoints 0 None
2011-05-25 New findings from STELARA psoriasis clinical trial to be presented at 22nd World Congress of Dermatology 0 None
2011-05-25 Oral and injected steroids appear to be equally effective for sudden hearing loss 0 None
2011-05-25 CRT, Cancer Research UK and Centella partner to launch clinical development of CEN-209 0 None
2011-05-25 Two Novartis ACZ885 Phase III trial data in severe gouty arthritis to be presented at EULAR 2011 0 None
2011-05-25 Conference reviews recent evidence that links aspirin use with reduced risk of several cancers 0 None
2011-05-25 New clinical research study to compare two medications for bipolar disorder 1 None
2011-05-25 Positive interim results from new bladder cancer therapy trial 0 None
2011-05-25 ImmunoCellular to present new ICT-107 Phase I trial data in glioblastoma multiforme at ASCO 2011 0 None
2011-05-24 Patient accrual complete in Provectus PH-10 Phase 2C clinical trial for treatment of psoriasis 0 None
2011-05-24 3M, Radius collaborate to develop BA058 for treatment of osteoporosis 0 None
2011-05-24 Azilsartan medoxomil-CLD phase 3 study results in systolic blood pressure presented at ASH 2011 0 5
2011-05-24 Altor receives NHLBI SBIR grant to complete ALT-836 second Phase 2 trial in ALI/ARDS 0 None
2011-05-24 VBL to present updated VB-111 Phase 1 trial results in advanced metastatic cancer at ASCO 2011 0 None
2011-05-24 Inotuzumab ozogamicin achieves over 50% response rate against acute lymphoblastic leukemia 0 None
2011-05-24 Journal of Clinical Oncology publishes Exelixis' cabozantinib phase 1 trial results in lymphoma 0 None
2011-05-23 Positive results from Relypsa RLY5016 Phase 2 trial to be presented at American Society of Hypertension meeting 0 None
2011-05-23 Sangamo announces presentations of ZFP Therapeutics data at ASGCT 2011 0 None
2011-05-23 Micromet's blinatumomab data to be presented at two upcoming medical meetings 0 None
2011-05-23 Pieris' PRS-080 preclinical data in anemia presented at International BioIron Society Meeting 0 None
2011-05-23 New RHUCIN study data in acute HAE attacks presented at 7th C1 Inhibitor Deficiency Workshop 0 None
2011-05-23 Phytoceuticals to present promising clinical data on 1 PRIMARY WOUND DRESSING at EWMA 2011 0 None
2011-05-23 New data from ProSavin Phase I/II trial in Parkinson's presented at ASGCT annual meeting 1 5
2011-05-23 Eplerenone reduces new onset atrial fibrillation and flutter in patients with class 2 heart failure 0 None
2011-05-21 Lilly Phase I multiple myeloma study affirms potential of LY2127399-bortezomib combination 0 None
2011-05-21 Phase 3 open-label study of RELISTOR presented at American Pain Society meeting 0 None
2011-05-21 Bristol-Myers Squibb to present abstracts on oncology compounds at ASCO 2011 Annual Meeting 0 None
2011-05-21 Data from Seattle Genetics' brentuximab vedotin, SGN-75 programs to be presented at ASCO 2011 0 None
2011-05-20 Jennerex presents positive preliminary data from JX-594 Phase 2 trial for advanced liver cancer 0 None
2011-05-20 Medivir reports positive results from ASPIRE TMC435 phase 2b study for genotype 1 chronic hepatitis C 0 None
2011-05-20 RTOG reports on largest trial for newly diagnosed glioblastoma 0 None
2011-05-20 AMT presents long-term efficacy study of Glybera in treatment of lipoprotein lipase deficiency 0 5
2011-05-20 Bayer, Onyx to present Nexavar-chemotherapy combination Phase 2b trial data in breast cancer at ASCO 2011 0 None
2011-05-20 VBL to present positive VB-111 preclinical data in metastatic lung cancer at 14th ASGCT 0 None
2011-05-20 Lilly's cixutumumab Phase II study results in five subtypes of sarcoma to be presented at 47th ASCO 0 None
2011-05-20 Positive results from Onyx's carfilzomib Phase 2b 003-A1 study in relapsed and refractory multiple myeloma 0 None
2011-05-20 ViroPharma commences VP 20621 Phase 2 study for prevention of recurrent Clostridium difficile infection 0 None
2011-05-20 CEL-SCI initiates global Multikine Phase III trial for head and neck cancer in Russia 0 5
2011-05-19 Enzon to discontinue PEG-SN38 clinical program in metastatic colorectal cancer 0 None
2011-05-19 Advantagene reaches SPA agreement with FDA for ProstAtak Phase 3 trial to prevent prostate cancer recurrence 0 None
2011-05-19 Metabolex commences arhalofenate Phase 2 clinical trial for treatment of hyperuricemia and gout 1 None
2011-05-19 PolyMedix's PMX-30063 compound mitigates ulcerative mucositis in pre-clinical studies 0 None
2011-05-19 RXi to present updated NeuVax Phase II trial data in breast cancer at ASCO 2011 0 None
2011-05-19 Repligen receives approval from FDA to commence RG3039 Phase 1 trial in Spinal Muscular Atrophy 0 None
2011-05-19 Isis receives $5M milestone payment from GSK for initiating ISIS-TTRRx Phase 1 study 0 None
2011-05-19 Omeros advances OMS103HP and OMS302 into Phase 3 clinical programs 0 None
2011-05-19 AstraZeneca announces encouraging results from olaparib phase II study in serous ovarian cancer 0 None
2011-05-19 TissueGene commences enrollment in TG-C Phase II trial for severe knee osteoarthritis 0 None
2011-05-19 YM BioSciences announces updated interim results from CYT387 Phase I/II trial in myelofibrosis 0 None
2011-05-19 Silence to present new Atu027 Phase I study data in advanced solid tumors at ASCO annual meeting 0 None
2011-05-19 Pfizer's axitinib Phase 3 trial in advanced renal cell carcinoma meets primary endpoints 0 None
2011-05-19 Nektar to present new NKTR-102 Phase 2 clinical data in multiple cancers at ASCO annual meeting 0 None
2011-05-19 Mpex, Synteract partner for cystic fibrosis fundraising event 0 None
2011-05-19 Biothera begins dosing in Imprime PGG and cetuximab combination Phase III trial for colorectal cancer 0 None
2011-05-18 Pharma Two B plans to initiate P2B001 Phase II study in Parkinson's disease 0 None
2011-05-18 New data on personalized approaches for skin, ovarian and lung cancer to be presented at ASCO meeting 0 None
2011-05-18 New denosumab Phase III trial data in high-risk prostate cancer presented at AUA conference 0 None
2011-05-18 JCO publishes Micromet's blinatumomab Phase 2 trial data in acute lymphoblastic leukemia 0 5
2011-05-18 Bayer HealthCare to present results on investigational oncology compounds at ASCO annual meeting 0 None
2011-05-18 CITN selects Cytheris' CYT107 for initial clinical trials at network institutions 0 None
2011-05-18 Amgen announces primary results from XGEVA Phase 3 trial in castrate-resistant prostate cancer 0 None
2011-05-18 Avanafil long-term phase 3 trial in erectile dysfunction meets primary endpoints 0 5
2011-05-18 Endo and Bioniche present Urocidin Phase III trial preliminary results at 2011 AUA annual meeting 0 None
2011-05-18 Positive results from Astellas Pharma's mirabegron phase III trial in overactive bladder 0 None
2011-05-18 CEL-SCI initiates Multikine Phase III trial for head and neck cancer in Canada 0 None
2011-05-18 Anacor Pharmaceuticals initiates AN2728, AN2898 Phase 2 trial in mild-to-moderate atopic dermatitis 0 None
2011-05-17 Preliminary topline results from Teva, CureTech's CT-011 Phase II trial in Diffuse Large B Cell Lymphoma 0 None
2011-05-17 Thrombolytic therapy linked to poor survival in pulmonary embolism patients with normal blood pressure 0 None
2011-05-17 Sanofi hopes to launch dengue vaccine in 2014 0 4
2011-05-17 SYMBICORT long-term comparative study data in African American asthma patients presented at ATS 2011 0 None
2011-05-17 Linezolid more effective than vancomycin in treating ventilated patients with MRSA pneumonia: Study 0 None
2011-05-16 Positive pirfenidone data in idiopathic pulmonary fibrosis to be presented at ATS conference 0 None
2011-05-16 Journal of Burn Care & Research publishes Caldolor clinical study data in hospitalized patients 0 3
2011-05-16 Positive results from EXPAREL Phase 3 study to be presented at ASCRS Annual Scientific Meeting 0 None
2011-05-16 Synexus completes CT327 phase II psoriasis trial for Creabilis 0 3
2011-05-16 New lenalidomide phase III study data presented at 13th International Myeloma Workshop 0 None
2011-05-16 Early HIV treatment can reduce transmission risk by 96%, preliminary study results show 0 None
2011-05-16 Roche initiates TB-403 Phase Ib/II study in glioblastoma multiforme 0 None
2011-05-16 VAYA Pharma's Vayarin now available in South, North Carolina and Texas for children with ADHD 1 3
2011-05-16 Otsuka Pharmaceutical reports OPC-34712 Phase 2 trial results in major depressive disorder 0 None
2011-05-16 The Lancet publishes two pirfenidone Phase 3 trial results in idiopathic pulmonary fibrosis 0 None
2011-05-13 CEL-SCI initiates Multikine Phase III trial for head and neck cancer in Poland 0 None
2011-05-13 ZIOPHARM submits IND with FDA for Ad-RTS-IL-12 Phase I study in cancer 0 None
2011-05-13 Two DIFICID Phase 3 trial data in C. difficile infection presented at AGS Annual Meeting 0 None
2011-05-13 Early antiretroviral treatment can halt HIV spread in couples 0 None
2011-05-12 Trillium raises $1 million to advance TTI-1612 into clinical trials for interstitial cystitis treatment 0 None
2011-05-12 New clinical data affirms safety profile of PolyMedix's PMX-30063 in treatment of Staph infections 0 None
2011-05-12 CrystalGenomics receives draft CSR for CG400549 Phase I MAD study in Staph infections 0 None
2011-05-12 Atox Bio completes AB103 phase 1 study in severe bacterial infections and sepsis 0 None
2011-05-12 Amira to present AM152 preclinical data in fibrotic disease at ATS Annual Meeting 0 None
2011-05-12 Tosedostat and OPAXIO study results to be presented at ASCO Annual Meeting 0 None
2011-05-12 GSK, NanoBio initiate two NB-001 Phase 3 trials in cold sores 0 None
2011-05-11 Santaris Pharma advances SPC4955 into Phase 1 trial for high cholesterol treatment 0 None
2011-05-11 ImmunID, Centre Léon Bérard and Cytheris commence CYT107-XELODA Phase IIa trial in metastatic breast cancer 0 None
2011-05-11 Symphogen to present second-generation Sympress platform at ESACT conference 0 None
2011-05-11 TSA, Psyadon Pharmaceuticals partner for ecopipam clinical trial in Tourette Syndrome 0 None
2011-05-11 Impax Pharmaceuticals initiates IPX159 Phase I study in Restless Legs Syndrome 0 None
2011-05-11 GATTEX Phase 3 study results in adult short bowel syndrome presented at DDW 2011 0 None
2011-05-11 Two DIFICID Phase 3 trial data in C. difficile presented at DDW conference 0 None
2011-05-11 Journal of Rheumatology publishes positive results from Cimzia Phase III trial in RA 0 None
2011-05-11 Inovio first quarter total revenue increases to $3.1 million for 2011 0 None
2011-05-11 Two DIFICID Phase 3 study data in C. difficile presented at ECCMID conference 0 None
2011-05-11 New drug targets bile acid to provide relief from constipation 0 None
2011-05-11 New Crohn’s disease therapy on its way 1 None
2011-05-10 Dalbavancin surveillance antibiotic results for Gram-positive pathogens presented at ECCMID meeting 0 None
2011-05-10 Independent investigator begins pump trial of Biodel's two ultra-rapid human insulin formulations 0 None
2011-05-10 Tetraphase presents TP-434, TP-2758 antibiotics study data against pathogens at ECCMID 0 None
2011-05-10 biocrea and Pfizer jointly presented details on novel PDE10 inhibitors 0 None
2011-05-10 Bayer's regorafenib granted FDA Fast Track designation for treatment of GIST 0 None
2011-05-10 Treatment with estrogen-lowering drugs shrinks tumors and reduces mastectomy rates in breast cancer patients 0 None
2011-05-10 Pfizer presents SA3Ag staphylococcal vaccine Phase 1 trial data at ECCMID/ICC 0 None
2011-05-10 MGH, Duke University and Angion Biomedica partner to develop novel therapeutics for ischemic stroke 0 None
2011-05-10 OncoGenex first quarter revenue decreases to $1.2 million 0 None
2011-05-10 Kowa presents three K-115 study results against glaucoma at ARVO 2011 0 None
2011-05-10 Nexvax2- coeliac disease vaccine shows promising results in Phase I clinical trial 0 5
2011-05-10 Acceleron presents RAP-661 preclinical data in osteopenic mice at international meeting 0 None
2011-05-10 Abbott, Sucampo present lubiprostone phase 3 trial data in Japanese CIC at DDW 2011 0 None
2011-05-09 Uganda: First vaccination for GMZ2 malaria vaccine trial 0 None
2011-05-09 New GARDASIL data against Human Papillomavirus presented at EUROGIN conference 0 3
2011-05-09 GTx reports net loss of $2.6 million for first quarter 2011 0 None
2011-05-09 EMA agrees to Swedish Orphan Biovitrum, Biogen Idec's pediatric rFIXFc trial in hemophilia 0 None
2011-05-09 Inovio reports VGX-3100 Phase I study data in cervical dysplasia and cancer 0 None
2011-05-09 Diamyd Medical announces European Phase III study results in type 1 diabetes 0 None
2011-05-07 Cempra to present solithromycin Phase 1 study data at ECCMID/ICC meeting 0 None
2011-05-07 Millennium presents VELCADE Phase III trial data in multiple myeloma at IMW meeting 0 None
2011-05-06 ImmunoCellular reports updated ICT-107 Phase I trial data in glioblastoma multiforme 0 None
2011-05-06 Millennium presents three studies in relapsed multiple myeloma at IMW meeting 0 None
2011-05-06 Pacira to present EXPAREL data in postsurgical pain at two medical meetings 0 None
2011-05-06 Omeros' PDE7 program expands addiction franchise 0 None
2011-05-06 MMRF, APGD collaborate to develop OSI-906 for relapsed multiple myeloma treatment 0 None
2011-05-06 Furiex Pharmaceuticals to present two JNJ-Q2 antibiotic abstracts at ECCMID/ ICC congress 0 None
2011-05-05 Promedior's PRM-151 clinical data in idiopathic pulmonary fibrosis to be presented at ATS 2011 0 None
2011-05-05 Over 1000 patients enrolled in world's largest ever pancreatic cancer vaccine trial 0 None
2011-05-05 Clinical study: Celecoxib drug may treat breast cancer 0 None
2011-05-05 CEL-SCI receives Polish government approval to commence Multikine Phase III clinical trial in head, neck cancer 0 None
2011-05-05 Selexys begins patient enrollment in SelG1 Phase I study for sickle cell disease 0 None
2011-05-04 FibroGen announces proof-of-principle for FG-4592 Phase 2 study in hemodialysis patients 0 None
2011-05-04 PolyMedix Phase 1B/2 clinical study data presented at ATVB meeting 0 None
2011-05-04 SARcode reports encouraging data from SAR 1118 Phase 2 dry eye trial 0 None
2011-05-04 pSivida presents data of ILUVIEN Phase 3 trial in Diabetic Macular Edema at ARVO 2011 0 None
2011-05-04 Top-line results from Lymphoseek NEO3-09 Phase 3 study in breast cancer, melanoma 0 None
2011-05-03 Nile Therapeutics initiates cenderitide Phase I trial in heart failure 0 None
2011-05-03 Santarus' budesonide MMX Phase III data in ulcerative colitis to be presented at DDW 2011 0 None
2011-05-03 Affinium announces AFN-1252 Phase I study results in staphylococcal infections 0 None
2011-05-03 Esperion reports positive results from ETC-1002 Phase 1 study in dyslipidemia 0 None
2011-05-03 Merck's Phase III study shows efficacy results of tafluprost to treat ocular hypertension 0 None
2011-05-03 Diabetes cell implant company approved for Argentina clinical trial 0 None
2011-05-02 Positive Ellex 2RT data demonstrates efficacy in treatment of early Age-Related Macular Degeneration 0 None

Total

178 posts
6 comments
16 raters